DFIB Cardiac Science (MM)

Florida Department of Transportation Purchases Cardiac Science Powerheart(R) AEDs for Safety Patrol Vehicle Fleet Vehicles Patrolling Florida's Turnpike Now Equipped With Life-Saving Devices IRVINE, Calif., May 26 /PRNewswire-FirstCall/ -- Cardiac Science Inc. (NASDAQ:DFIB), a leading manufacturer of live-saving automatic public-access defibrillators (AEDs), announced today that Florida's Turnpike Enterprise, a division of the Florida Department of Transportation, has purchased Powerheart(R) AEDs for deployment in the fleet of Safety Patrol trucks. The placement of the AEDs in the Safety Patrol trucks follows recent deployments of Cardiac Science AEDs in Florida's Turnpike service plazas and headquarters facilities, said Richard Nelson, Director of Business Development and Concessions Management for Florida's Turnpike Enterprise. The AEDs were deployed in the Safety Patrol trucks this week and the drivers have received comprehensive training in their use, Nelson added. "These Powerheart AEDs are a valuable addition to the vehicles in our Road Ranger program dedicated solely to patrolling the Sawgrass Expressway and Florida's Turnpike mainline and helping motorists in need," Nelson said. "We have worked alongside Cardiac Science to deploy their AEDs, first in our facilities and now in the Safety Patrol vehicles, as well as with the training of the drivers. I feel certain these automatic defibrillators will prove their value in the near future by saving lives either out on our roadways or in our office buildings." Florida's Turnpike Road Ranger program and the Safety Patrol trucks are sponsored by State Farm. The trucks patrol the Sawgrass Expressway and Florida's Turnpike's 309-mile mainline which extends from Dade City to I-75 in Sumter County, clear debris from the roadway and offer free roadside assistance for stranded motorists A press conference related to the AED deployment and other matters focused on the safety along Florida's Turnpike system has been announced by Florida Turnpike Enterprise and will be held at 11 a.m. Thursday, May 26 (today) at the Turkey Lake Service Plaza in Orlando. About Cardiac Science Cardiac Science develops, manufactures and markets a complete line of Powerheart(R) brand, automatic public access defibrillators (AEDs), and offers comprehensive AED/CPR training and AED program management services that facilitate successful deployments. The company makes the Powerheart(R) CRM(TM), the only FDA-cleared therapeutic patient monitor that instantly and automatically treats hospitalized cardiac patients who suffer life-threatening heart rhythms. Cardiac Science also manufactures its AED products on a private label basis for other leading medical companies such as Nihon Kohden (Japan), Quinton Cardiology Systems and GE Healthcare. For more information please visit http://www.cardiacscience.com/ or call 1.949.797.3800. This press release includes forward-looking statements. These statements may be identified by the use of forward-looking terminology such as "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "might," "plan," "potential," "predict," "should," or "will," or the negative thereof or other variations thereon or comparable terminology. Cardiac Science has based these forward-looking statements on the current expectations, assumptions, estimates and projections. While Cardiac Science believes the Florida Turnpike Enterprise deployment to be a benefit to the citizens of the region and will save lives, these expectations, assumptions, estimates and projections, while reasonable, are forward-looking statements and are only predictions and involve known and unknown risks and uncertainties, many of which are beyond our control. Certain factors, including those discussed in Cardiac Sciences' Annual Report on Form 10-K for the year ended December 31, 2004, under the heading "Risk Factors," may cause the actual results, performance or achievements to differ materially from any future results, performance or achievements expressed or implied by these forward-looking statements. Given these risks and uncertainties, you are cautioned not to place undue reliance on such forward-looking statements. We do not undertake any obligation to update any such statements or to publicly announce the results of any revisions to any such statements to reflect future events or developments. Contact: Matt Clawson (Investors) Michael D. Gioffredi Len Hall (Media) Chief Marketing Officer Allen & Caron Inc Cardiac Science, Inc. (949) 474-4300 (949) 797-3800 DATASOURCE: Cardiac Science Inc. CONTACT: Investors, Matt Clawson, , or Media, Len Hall, , both of Allen & Caron Inc, +1-949-474-4300, for Cardiac Science Inc.; or Michael D. Gioffredi, Chief Marketing Officer of Cardiac Science, Inc., +1-949-797-3800, Web site: http://www.cardiacscience.com/

Copyright